Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Waverley Pharma Inc
V.WAVE
Healthcare
Biotechnology
Waverley Pharma Inc. is a biopharmaceutical company engaged in the research, development, and commercialization of human therapeutics focused on oncology. Its primary focus is the PARP-1 program and secondary focus is the generic oncology injectable market in European Union, the United Kingdom (UK) and North America. It has entered into a license, manufacture, supply, marketing and distribution...
agreement with Reliance Life Sciences Private Limited, which has granted it an exclusive territorial license to market and sell capecitabine in the UK and Germany as well as a non-exclusive territorial license to market and sell temozolomide and erlotinib in the UK. Its generic oncology products include bortezomib and pemetrexed. Bortezomib is an injectable generic chemotherapy drug, developed for the treatment of multiple myeloma and mantle cell lymphoma. Pemetrexed is an injectable generic chemotherapy drug, developed for the treatment of non-small cell lung cancer and pleural mesothelioma.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:WAVE)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(264)
•••
moneywinner1
X
View Profile
View Bullboard History
Comment by
moneywinner1
on Aug 13, 2020 10:31am
RE:RE:MC $8 M / 5 Cancer Drug approved /2 BIG Drug approval in Q4
It looks like good news is near , if closed tomorrow at 0.25-0.30 than watch on Monday 300-400 up to $1-$1.30
(70)
•••
pinkfloyd90
X
View Profile
View Bullboard History
Comment by
pinkfloyd90
on Aug 13, 2020 10:01am
RE:More Drug Approvals & Product Deals before year end
thanks for the post...
(264)
•••
moneywinner1
X
View Profile
View Bullboard History
Comment by
moneywinner1
on Aug 13, 2020 8:53am
RE:MC $8 M / 5 Cancer Drug approved /2 BIG Drug approval in Q4
Pipeline https://www.waverleypharma.com/generic-product-pipeline.html WAV-101 is an injectable generic chemotherapy drug development for the treatment of non-small cell lung cancer and other
...more
(19)
•••
Stocks2Go
X
View Profile
View Bullboard History
Comment by
Stocks2Go
on Aug 12, 2020 1:55pm
RE:Volume & price up now for no reason
I think you will be back in the mid 20's very shortly.
(747)
•••
MidtownGuy
X
View Profile
View Bullboard History
Post by
MidtownGuy
on Aug 12, 2020 1:47pm
Volume & price up now for no reason
These stocks frustrate me to no end. But as a bagholder in the mid 20s, I'll take it.
(8)
•••
ezemoney
X
View Profile
View Bullboard History
Comment by
ezemoney
on Aug 12, 2020 1:42pm
RE:Moving Back Up Now.
I took a tidy profit today. This stock always comes back home in the low teens so I wait for it to come back home to Daddy.
(19)
•••
Stocks2Go
X
View Profile
View Bullboard History
Post by
Stocks2Go
on Aug 12, 2020 1:30pm
Moving Back Up Now.
I saw how fast this took off last time. Incredible.
(14)
•••
Aman0808
X
View Profile
View Bullboard History
Comment by
Aman0808
on Aug 12, 2020 1:02pm
RE:RE:MC $8 M / 5 Cancer Drug approved /2 BIG Drug approval in Q4
Thanks for posting this. Looking to get it and was hoping my understanding is correct that WAVE needs to wait until the patents expire and then they will have a sales pipeline of teh generic version
...more
(18)
•••
Investor62
X
View Profile
View Bullboard History
Comment by
Investor62
on Aug 12, 2020 11:17am
RE:MC $8 M / 5 Cancer Drug approved /2 BIG Drug approval in Q4
I just got the following from the company: Currently both of these products are still protected by patents until early next year (in most cases; varies country by country). However, by obtaining
...more
(264)
•••
moneywinner1
X
View Profile
View Bullboard History
Post by
moneywinner1
on Aug 12, 2020 8:54am
Today I should get my shares
Like I said before 0.15 I will be buying back and expect news to back to 0.30 , now I'm positive on fill and potential to make money
(81)
•••
2skytracker2
X
View Profile
View Bullboard History
Comment by
2skytracker2
on Aug 11, 2020 6:12pm
RE:Tomorrow I will get filled
And I will buy more if it hits .15 GLTA
(264)
•••
moneywinner1
X
View Profile
View Bullboard History
Post by
moneywinner1
on Aug 11, 2020 4:22pm
Tomorrow I will get filled
0.15 and lower
(15)
•••
bullmarkets
X
View Profile
View Bullboard History
Comment by
bullmarkets
on Aug 11, 2020 12:33pm
RE:Wave --new "Sedar" filing
They are a 300-500 million ( maybe more by now ) and would have had to pay more than current price. Between 25-35 cents would be my guess on cost.
(5)
•••
tankingfrank
X
View Profile
View Bullboard History
Comment by
tankingfrank
on Aug 11, 2020 10:35am
RE:Wave --new "Sedar" filing
thats good news, basically means there is no float. why did they have to file? they are under 10%
(6)
•••
Goldblack
X
View Profile
View Bullboard History
Post by
Goldblack
on Aug 11, 2020 10:17am
Wave --new "Sedar" filing
As of 07/31/2020 an institutional investor(MMCAP International inc) now owns 4.773 mil sharers or 8.84% of issued capital.GLTA
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover Options Trading Strategies to Minimize your Tax Burden